# US 2024/0198110 A1 · Systems and methods for monitoring and revising electrical stimulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198110 A1
- Document ID: US20240198110A1
- Status: Published application
- Kind: A1
- Application number: 18/535,655
- Filed: 2023-12-11
- Published: 2024-06-20
- Earliest claimed: 2022-12-14
- Assignees: Boston Scientific Neuromodulation Corporation
- Applicants: Boston Scientific Neuromodulation Corporation
- Inventors: Lisa Denise Moore
- Web page: https://patentgrep.com/patent/US20240198110A1

## CPC

- A61N 1/36139: {with automatic adjustment}
- A61N 1/36132: {using patient feedback}
- A61N 1/37235: {Aspects of the external programmer}
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 40/67: for remote operation
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A method for monitoring and revising electrical stimulation over time includes obtaining or determining i) a therapeutic effects value and a side effects value for a first set of stimulation parameter values or ii) a therapeutic effect threshold value or side effect threshold value for an electrode selection of the first set of stimulation parameter values; performing clinical effects determinations for at least the first set of stimulation parameter values at points in time extending over at least one week; evaluating the clinical effects determinations to identify any difference from the therapeutic effects value, the side effects value, the therapeutic effect threshold value, or the side effect threshold value over time; and, when the difference meets or exceeds a threshold, recommending or implementing a new set of stimulation parameter values based on previous clinical effects determinations.

## Claims

### Claim 1

A method for monitoring and revising electrical stimulation over time, the method comprising:
obtaining or determining i) a therapeutic effects value and a side effects value for a first set of stimulation parameter values or ii) a therapeutic effect threshold value or side effect threshold value for an electrode selection of the first set of stimulation parameter values;
performing clinical effects determinations for at least the first set of stimulation parameter values at a plurality of points in time extending over at least one week;
evaluating, by a processor, the clinical effects determinations to identify any difference from the therapeutic effects value, the side effects value, the therapeutic effect threshold value, or the side effect threshold value over time; and
when the difference from the therapeutic effects value, the side effects value, the therapeutic effect threshold value, or the side effect threshold value meets or exceeds a threshold, recommending or implementing, by the processor and without human intervention, a new set of stimulation parameter values based on previous clinical effects determinations.

### Claim 2 (depends on 1)

The method of claim 1, wherein the side effects value is indicative of no side effects or side effects below a threshold level.

### Claim 3 (depends on 1)

The method of claim 1, wherein the threshold comprises an increase in side effects above a threshold level or by a threshold amount.

### Claim 4 (depends on 1)

The method of claim 1, wherein the threshold comprises identifying, or achieving a threshold level of, a new side effect.

### Claim 5 (depends on 1)

The method of claim 1, wherein the threshold comprises a decrease in therapeutic effect below a threshold level or by a threshold amount.

### Claim 6 (depends on 1)

The method of claim 1, further comprising receiving a request to perform a one of the clinical effects determinations.

### Claim 7 (depends on 1)

The method of claim 1, further comprising performing additional clinical effects determinations for a plurality of additional sets of stimulation parameter values.

### Claim 8 (depends on 1)

The method of claim 1, further comprising generating a clinical effects map using one or more of the clinical effects determinations and one or more of the additional clinical effects determinations.

### Claim 9 (depends on 8)

The method of claim 8, wherein generating the clinical effects map comprising weighting at least one of the clinical effects determinations based on an age of the at least one of the clinical effects determinations.

### Claim 10 (depends on 1)

The method of claim 1, wherein the performing comprises obtaining sensor data to assist in determining at least one of the clinical effects determinations.

### Claim 11 (depends on 1)

The method of claim 1, wherein the performing comprises obtaining patient feedback or patient questionnaire to assist in determining at least one of the clinical effects determinations.

### Claim 12 (depends on 1)

A non-transitory computer-readable medium having processor-executable instructions for monitoring stimulation drift, the processor-executable instructions when installed onto a device enable the device to perform actions, the actions comprising the method of claim 1.

### Claim 13

A method for monitoring and revising electrical stimulation over time, the method comprising:
obtaining or determining a first therapeutic effects value or first therapeutic effect threshold value for a first set of stimulation parameter values;
performing a determination of a subsequent therapeutic effects value or a subsequent therapeutic threshold value for at least the first set of stimulation parameter values at a plurality of points in time extending over at least one week;
evaluating, by a processor, the subsequent therapeutic effects values or subsequent therapeutic threshold values to identify a difference from the first therapeutic effects value or first therapeutic threshold value, respectively; and
when the difference from the first therapeutic effects value or first therapeutic threshold value exceeds a threshold, recommending or implementing, by the processor and without human intervention, a new set of stimulation parameter values based on previous clinical effects determinations.

### Claim 14 (depends on 13)

The method of claim 13, wherein the threshold comprises a decrease in therapeutic effect below a threshold level or by a threshold amount.

### Claim 15 (depends on 13)

The method of claim 13, further comprising generating a clinical effects map using one or more of the clinical effects determinations and one or more of the additional clinical effects determinations.

### Claim 16 (depends on 13)

A non-transitory computer-readable medium having processor-executable instructions for monitoring stimulation drift, the processor-executable instructions when installed onto a device enable the device to perform actions, the actions comprising the method of claim 13.

### Claim 17

A method for monitoring and revising electrical stimulation over time, the method comprising:
stimulating a patient using a first set of stimulation parameter values;
performing a determination of side effects for the stimulation at a plurality of points in time extending over at least one week; and
when the determination exceeds a side effects threshold or identifies a new side effect, recommending or implementing, by the processor and without human intervention, a new set of stimulation parameter values based on previous clinical effects determinations.

### Claim 18 (depends on 17)

The method of claim 17, further comprising generating a clinical effects map using one or more of the clinical effects determinations and one or more of the additional clinical effects determinations.

### Claim 19 (depends on 17)

The method of claim 17, wherein the performing comprises obtaining sensor data to assist in determining at least one of the clinical effects determinations.

### Claim 20 (depends on 17)

The method of claim 17, wherein the performing comprises obtaining patient feedback or patient questionnaire to assist in determining at least one of the clinical effects determinations.
